Atherosclerosis

Local Superfund site may contribute to inorganic arsenic exposure

Endocrinologists urged to pay attention to COORDINATE trial

Repurposed anti-inflammatory drug may be used alone or in combination with standard meds

Men with hypogonadism and heart disease or risk factors saw no increased risk vs placebo

48-mm Xience stent surprised with low restenosis at 1 year

Earlier signal of noncardiovascular mortality refuted by large meta-analysis

Early results promising with DynamX bioadaptor, though traditional BRS hasn't been abandoned

Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however

If finerenone isn't available, try spironolactone, said researcher

Twin study suggests a difference in CVD impact from becoming obese despite "good genes"

Natural history study lays the groundwork for intervention trials

The technique was not linked to a reduction in postoperative pulmonary complications

Residual inflammation is important factor of cardiovascular risk

Effects observed in inflammation and improved clinical outcomes